Trademark: EVELO 2061021
Word
EVELO
ID
2061021
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
03 January 2020
Registration Date
03 January 2020
Renewal Date
03 January 2030
Owner(s)
Service
Maddocks
Goods and Services:
Class 5:
Pharmaceutical preparations and substances; pharmaceuticals used to prevent and treat disease in the nature of cancer, cancer symptoms, cancer-related diseases and side effects of cancer therapies; pharmaceuticals used to prevent disease in the nature of inflammation, neuro-inflammation, and autoimmune diseases; pharmaceuticals used to prevent disease in the nature of allergies and disrupted microbial community associated with allergies; pharmaceuticals used to prevent disease in the nature of metabolic disorders; pharmaceuticals used to prevent cardiovascular, neuro-degenerative, and neuro-psychiatric diseases; pharmaceuticals used to prevent, treat and cure neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to prevent, treat and cure inflammation, neuro-inflammation, and autoimmune diseases and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to prevent, treat and cure allergies and disrupted microbial community associated with allergies in human and animal subjects; pharmaceuticals used to prevent, treat and cure metabolic disorders and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to prevent, treat and cure cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with the aforementioned conditions; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of inflammation, neuro-inflammation, and autoimmune diseases and disrupted microbial community associated with the aforementioned conditions; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of allergies and disrupted microbial community associated with allergies; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of metabolic disorders and disrupted microbial community associated with the aforementioned conditions; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases and disrupted microbial community associated with the aforementioned conditions; live bacteria, inactivated bacteria, recombinant bacteria and bacterial extracts; biological preparations in the nature of microorganisms to prevent disease in the nature of neoplastic conditions and pre-neoplastic conditions in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of inflammation, neuro-inflammation, and autoimmune diseases in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of allergies in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of metabolic disorders in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases; biological preparations in the nature of microorganisms to treat and cure neoplastic conditions and pre-neoplastic conditions in animal or human subjects; biological preparations in the nature of microorganisms to treat and cure inflammation and autoimmune diseases in animal or human subjects; biological preparations in the nature of microorganisms to treat and cure allergies in animal or human subjects; biological preparations in the nature of microorganisms to treat and cure metabolic disorders and cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases in animal or human subjects; biological preparations in the nature of microorganisms to maintain and restore health in animal or human subjects via treatment of inflammation, neuro-inflammation, autoimmune diseases, allergies, metabolic disorders, cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases; biological preparations in the nature of microorganisms to maintain and restore health in animal or human subjects via treatment of neoplastic conditions and pre-neoplastic conditions; cultures of microorganisms and preparation of microorganisms in the nature of bacterial and bacteriological preparations, all for medical and veterinary purposes, the foregoing for medical purposes; vaccines; therapeutic vaccines; vaccine preparations; antibodies for medical purposes; monoclonal antibodies; biopharmaceuticals; biosimilars and biological preparations for medical purposes; biochemical preparations for medical purposes; test kits in this class; preparations, substances, reagents and agents for diagnostic and medical purposes
Pharmaceutical preparations and substances; pharmaceuticals used to prevent and treat disease in the nature of cancer, cancer symptoms, cancer-related diseases and side effects of cancer therapies; pharmaceuticals used to prevent disease in the nature of inflammation, neuro-inflammation, and autoimmune diseases; pharmaceuticals used to prevent disease in the nature of allergies and disrupted microbial community associated with allergies; pharmaceuticals used to prevent disease in the nature of metabolic disorders; pharmaceuticals used to prevent cardiovascular, neuro-degenerative, and neuro-psychiatric diseases; pharmaceuticals used to prevent, treat and cure neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to prevent, treat and cure inflammation, neuro-inflammation, and autoimmune diseases and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to prevent, treat and cure allergies and disrupted microbial community associated with allergies in human and animal subjects; pharmaceuticals used to prevent, treat and cure metabolic disorders and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to prevent, treat and cure cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases and disrupted microbial community associated with aforementioned conditions in human and animal subjects; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of neoplastic conditions, pre-neoplastic conditions and disrupted microbial community associated with the aforementioned conditions; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of inflammation, neuro-inflammation, and autoimmune diseases and disrupted microbial community associated with the aforementioned conditions; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of allergies and disrupted microbial community associated with allergies; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of metabolic disorders and disrupted microbial community associated with the aforementioned conditions; pharmaceuticals used to maintain and restore health to human or animal subjects via treatment of cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases and disrupted microbial community associated with the aforementioned conditions; live bacteria, inactivated bacteria, recombinant bacteria and bacterial extracts; biological preparations in the nature of microorganisms to prevent disease in the nature of neoplastic conditions and pre-neoplastic conditions in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of inflammation, neuro-inflammation, and autoimmune diseases in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of allergies in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of metabolic disorders in animal or human subjects; biological preparations in the nature of microorganisms to prevent disease in the nature of cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases; biological preparations in the nature of microorganisms to treat and cure neoplastic conditions and pre-neoplastic conditions in animal or human subjects; biological preparations in the nature of microorganisms to treat and cure inflammation and autoimmune diseases in animal or human subjects; biological preparations in the nature of microorganisms to treat and cure allergies in animal or human subjects; biological preparations in the nature of microorganisms to treat and cure metabolic disorders and cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases in animal or human subjects; biological preparations in the nature of microorganisms to maintain and restore health in animal or human subjects via treatment of inflammation, neuro-inflammation, autoimmune diseases, allergies, metabolic disorders, cardiovascular, neuro-degenerative, neuro-inflammatory and neuro-psychiatric diseases; biological preparations in the nature of microorganisms to maintain and restore health in animal or human subjects via treatment of neoplastic conditions and pre-neoplastic conditions; cultures of microorganisms and preparation of microorganisms in the nature of bacterial and bacteriological preparations, all for medical and veterinary purposes, the foregoing for medical purposes; vaccines; therapeutic vaccines; vaccine preparations; antibodies for medical purposes; monoclonal antibodies; biopharmaceuticals; biosimilars and biological preparations for medical purposes; biochemical preparations for medical purposes; test kits in this class; preparations, substances, reagents and agents for diagnostic and medical purposes
Class 42:
Medical research; scientific research; pharmaceutical research; research and development services including scientific, medical, pharmaceutical, vaccine and biotechnology products research and development services; industrial analysis; clinical trials; conducting clinical trials; provision of testing facilities; management of scientific research projects; laboratory analysis and research; preparation of technical studies, technical reports, scientific reports; provision of research services and facilities, provision of research results, information and outcomes; provision of information, advisory and consultancy services relating to the aforementioned services including over a global computer network
Medical research; scientific research; pharmaceutical research; research and development services including scientific, medical, pharmaceutical, vaccine and biotechnology products research and development services; industrial analysis; clinical trials; conducting clinical trials; provision of testing facilities; management of scientific research projects; laboratory analysis and research; preparation of technical studies, technical reports, scientific reports; provision of research services and facilities, provision of research results, information and outcomes; provision of information, advisory and consultancy services relating to the aforementioned services including over a global computer network